Correlation Between Raphael Pharmaceutical and Sangui Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Raphael Pharmaceutical and Sangui Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Raphael Pharmaceutical and Sangui Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Raphael Pharmaceutical and Sangui Biotech International, you can compare the effects of market volatilities on Raphael Pharmaceutical and Sangui Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Raphael Pharmaceutical with a short position of Sangui Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Raphael Pharmaceutical and Sangui Biotech.

Diversification Opportunities for Raphael Pharmaceutical and Sangui Biotech

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Raphael and Sangui is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Raphael Pharmaceutical and Sangui Biotech International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangui Biotech Inter and Raphael Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Raphael Pharmaceutical are associated (or correlated) with Sangui Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangui Biotech Inter has no effect on the direction of Raphael Pharmaceutical i.e., Raphael Pharmaceutical and Sangui Biotech go up and down completely randomly.

Pair Corralation between Raphael Pharmaceutical and Sangui Biotech

If you would invest  0.15  in Sangui Biotech International on August 27, 2024 and sell it today you would earn a total of  0.00  from holding Sangui Biotech International or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Raphael Pharmaceutical  vs.  Sangui Biotech International

 Performance 
       Timeline  
Raphael Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Raphael Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Sangui Biotech Inter 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sangui Biotech International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental drivers, Sangui Biotech is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Raphael Pharmaceutical and Sangui Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Raphael Pharmaceutical and Sangui Biotech

The main advantage of trading using opposite Raphael Pharmaceutical and Sangui Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Raphael Pharmaceutical position performs unexpectedly, Sangui Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangui Biotech will offset losses from the drop in Sangui Biotech's long position.
The idea behind Raphael Pharmaceutical and Sangui Biotech International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes